The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the …
Monthly Archives: February 2023
Idiopathic Pulmonary Fibrosis Management Market is expected to reach US$ 3649.90 Million by 2033 | FMI
The global Idiopathic Pulmonary Fibrosis Management Market is expected to generate a market value of US$ 3145 Million in 2023 and a market value of US$ 3649.90 Million by 2033, with a CAGR of 1.5% from 2023 to 2033. The increasing prevalence of the disease in males around the world has contributed to the growth …
The Global Encephalitis Treatment Market Is Expected to Register Growth at 5.4% CAGR through 2033 | FMI Study
The global Encephalitis Treatment Market is currently valued at US$ 20.14 billion in 2023, with a CAGR of 5.4% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 34.08 billion by 2033. The major factor attributing to the growth of the market is the high mortality and morbidity rate caused …
Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2033 | FMI Study
The Cardiovascular Ultrasound Market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …
Liver Fibrosis Treatment Market to surge at an 11% CAGR until 2033, reaching US$ 46.65 billion | FMI Study
The global Liver Fibrosis Treatment Market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …
Next Generation Immunotherapies Market to reach US$ 268.84 billion by 2033, Monoclonal Antibodies were Primary Drug Class | FMI Report
The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …
Synthetic Biology Market to reach a valuation of ~US$ 138.8 Billion by the year 2032
The global synthetic biology market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …
Heterozygous Familial Hypercholesterolemia (HEFH) Management Market is expected to grow at a 14.5% CAGR from 2023 to 20232
In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …
Arthroscopy Visualization Systems Market estimated to surge ahead at a CAGR value of 7.1% from 2022 to 2032
According to Future Market Insights’ latest industry analysis, the market size for the global arthroscopy visualization systems market is expected to reach US$ 453.8 Mn in 2022. It is projected to exhibit growth at a CAGR of 7.1% over the forecast period, with estimated market size of US$ 902.5 Mn in 2032. The high demand for arthroscopy visualization systems due to an increase …
Synthetic Biology Market to reach a valuation of ~US$ 138.8 Billion by the year 2032.
The global synthetic biology market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately …